Articles published in Pharmacognosy Communications

Export 46 results:
Author Title Type [ Year(Asc)]
Filters: Author is Ian Edwin Cock  [Clear All Filters]
2016
Wang X, Zhang J, Cock IEdwin. Acai, cacao and maca extracts: Anticancer activity and growth inhibition of microbial triggers of selected autoimmune inflammatory diseases. Pharmacognosy Communications. 2016;6(4):204-214.  (677.76 KB)
Zhang J, Biggs I, Sirdaarta J, White A, Cock IEdwin. Antibacterial and Anticancer Properties of Boswellia carteri Birdw. and Commiphora molmol Engl. Oleo-Resin Solvent Extractions. Pharmacognosy Communications. 2016;6(3):120-136.  (108.02 KB)
Wright MHenry, Arnold MSarah Jean, Aldosary H, Sirdaarta J, Greene ACarlson, Cock IEdwin. Bioactive constituents of Terminalia ferdinandiana Exell: A pharmacognistic approach towards the prevention and treatment of yersiniosis. Pharmacognosy Communications. 2016;6(3):152-163.  (1.03 MB)
Cock IEdwin. Editorial. Pharmacognosy Communications. 2016;6(3):119.  (108.13 KB)
Cock IEdwin. Editorial. Pharmacognosy Communications. 2016;6(2):56-56.  (213.69 KB)
Cock IEdwin. Editorial. Pharmacognosy Communications. 2016;6(1):1-1.  (116.01 KB)
Cock IEdwin. Editorial. Pharmacognosy Communications. 2016;6(4):191-193.  (283.38 KB)
Lebaratoux P, Sirdaarta J, Rayan P, PA MDPAnn McDonn, Cock IEdwin. An Evaluation of the Antibacterial, Anti-Giardial, Anticancer and Toxicity Properties of Selected Nut Extracts. Pharmacognosy Communications. 2016;6(3):174-184.  (934.41 KB)
Biggs I, Sirdaarta J, White A, Cock IEdwin. GC-MS Analysis of Frankincense Extracts which Inhibit the Growth of Bacterial Triggers of Selected Autoimmune Diseases. Pharmacognosy Communications. 2016;6(1):10-22.  (1.36 MB)
Wright MHenry, Courtney R, Greene ACarlson, Cock IEdwin. Growth Inhibitory Activity of Indian Terminalia spp. against the Zoonotic Bacterium Bacillus anthracis. Pharmacognosy Communications. 2016;6(1):2-9.  (547.95 KB)
Wright MHenry, Lee CJay, Pollock CEstelle, Greene ACarlson, Cock IEdwin. Growth Inhibitory Activity of Selected High Antioxidant Australian Syzygium Species Against the Food Poisoning and Tissue Necrotic Pathogen Clostridium Perfringens. Pharmacognosy Communications. 2016;6(2):93-99.  (525.82 KB)
Bryant K, Cock IEdwin. Growth inhibitory properties of Backhousia myrtifolia Hook. & Harv. and Syzygium anisatum (Vickery) Craven & Biffen extracts against a panel of pathogenic bacteria. Pharmacognosy Communications. 2016;6(4):194-203.  (1.41 MB)
Mpala LNomathemba, Chikowe GRumbudzai, Cock IEdwin. Growth inhibitory properties of extracts prepared from selected Leptospermum and Melaleuca species against a panel of pathogenic bacteria. Pharmacognosy Communications. 2016;6(4):215-224.  (1.65 MB)
Lee CJay, Wright MHenry, Arnold MSarah Jean, Greene ACarlson, Cock IEdwin. Inhibition of Streptococcus pyogenes growth by native Australian plants: New approaches towards the management of impetigo, pharyngitis and rheumatic heart disease. Pharmacognosy Communications. 2016;6(3):164-173.  (594.65 KB)
Cock IEdwin. The Janus Corner. Pharmacognosy Communications. 2016;6(1):51-52.  (153.05 KB)
Cock IEdwin. The Janus Corner. Pharmacognosy Communications. 2016;6(2):112-114.  (347.45 KB)
Cock IEdwin. The Janus Corner. Pharmacognosy Communications. 2016;6(4):255-258.  (513.62 KB)
Cock IEdwin. The Janus Corner. Pharmacognosy Communications. 2016;6(3):185-187.  (513.63 KB)

Pages

Founded:  In 2004, as the PHCOG.NET – a non-profit private organization dedicated to Natural Products Research leading to develop promising drugs. Our main mission is to make information on herbal drug research readily available in different formats to suit the individual needs.

Pharmacognosy Communications [Phcog Commn.] is a new quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the  publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.

The journal aims to cater the latest outstanding developments in the field of pharmacognosy and natural products and drug design covering but not limited to the following topics:

  • Pharmacognosy and pharmacognistic investigations
  • Research based ethnopharmacological evaluations
  • Biological evaluation of crude extracts, essential oils and pure isolates
  • Natural product discovery and evaluation
  • Mechanistic studies
  • Method and technique development and evaluation
  • Isolation, identification and structural elucidation of natural products
  • Synthesis and transformation studies

Distinctions:  The most widely read, cited, and known Pharmacognosy Communications and website is well browsed with all the articles published. More than 20,000 readers in nearly every country in the world each month

Aim and Scope | Editorial Board | Indexed & Abstracted | Instruction to Authors | Manuscript Submission & Charges

Subjects Covered : Natural Products, Pharmacognosy, Phytochemistry, Marine Pharmacognosy and Zoo Pharmacognosy
ISSN :2249-0159 (Print) ; 2249-0167 (Online) Frequency : Quarterly Rapid at a time publication (4 issues/year)

Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online  publication is 45 days.
Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.